What are the causes of post‑dialysis hyperglycaemia in haemodialysis patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Post-Dialysis Hyperglycemia

Post-dialysis hyperglycemia occurs primarily due to impaired osmotic diuresis, post-dialysis meal intake after pre-dialysis fasting, and the accumulation of uremic toxins that contribute to insulin resistance. 1

Primary Mechanisms

Impaired Osmotic Diuresis

  • The kidneys normally excrete excess glucose through osmotic diuresis, but in hemodialysis patients this mechanism is absent, allowing glucose to accumulate after dialysis sessions 1

Post-Dialysis Meal Intake After Fasting

  • Patients typically fast before dialysis and then eat immediately afterward, creating a large glucose load that cannot be adequately cleared due to impaired renal function 1
  • This post-dialysis meal occurs at a time when insulin sensitivity is already compromised 1

Uremic Toxin Accumulation

  • Uremic toxins accumulate between dialysis sessions and contribute to insulin resistance and postprandial hyperglycemia 1
  • Although dialysis removes some uremic toxins and temporarily improves insulin sensitivity, the toxins re-accumulate between sessions 1

Dialysate-Related Factors

Glucose Concentration in Dialysate

  • The glucose concentration of the dialysate is the main determinant of plasma glucose levels after hemodialysis 1
  • Historically, high-glucose dialysate solutions (up to 1600 mg/dL) led to significant hyperglycemia 1
  • Even with modern glucose-free or low-glucose dialysates, rebound hyperglycemia can occur 2

Counterregulatory Response (Somogyi-Like Effect)

Rebound Hyperglycemia After Intradialytic Hypoglycemia

  • Several hours after hemodialysis completion, paradoxical rebound hyperglycemia may occur through a mechanism similar to the Somogyi effect 2
  • During dialysis, glucose levels progressively decline, reaching their lowest point at the end of the session, which triggers counterregulatory hormone release 1, 3
  • This hormonal response, combined with insulin resistance, causes glucose levels to peak approximately 2.5 hours after dialysis ends 4

Metabolic Changes During and After Dialysis

Increased Erythrocyte Glucose Uptake During Dialysis

  • During hemodialysis, increased erythrocyte glucose uptake contributes to lower glucose levels during the session 1
  • After dialysis ends, this mechanism reverses, contributing to glucose accumulation 1

Removal of Uremic Toxins Temporarily Improves Insulin Sensitivity

  • Dialysis removes uremic toxins, which paradoxically leads to less severe insulin resistance immediately post-dialysis 1
  • However, this improved sensitivity is short-lived as toxins re-accumulate, and the post-dialysis meal overwhelms this temporary improvement 1

Timing and Pattern

Predictable Glycemic Pattern

  • Glucose levels drop progressively during hemodialysis, reaching their nadir at the end of the dialysis session 1, 3, 2
  • Post-dialysis hyperglycemia typically peaks 2.5 hours after dialysis ends 4
  • This creates a characteristic pattern of intradialytic hypoglycemia followed by post-dialysis hyperglycemia 2, 5

Clinical Implications

Common Pitfall: Overtreatment of Post-Dialysis Hyperglycemia

  • Clinicians may be tempted to increase insulin doses in response to post-dialysis hyperglycemia, but this increases the risk of dangerous intradialytic and nocturnal hypoglycemia 4, 3
  • Target more moderate fasting glucose levels of 110-130 mg/dL rather than aggressive control, as very low HbA1c creates a U-shaped mortality curve in hemodialysis patients 4, 6, 3

Monitoring Strategy

  • Continuous glucose monitoring is superior to point-of-care testing for detecting these glycemic excursions, as traditional monitoring misses most episodes 1, 4, 3
  • Monitor glucose at minimum: pre-hemodialysis, mid-hemodialysis (2 hours), end of hemodialysis, and 2-3 hours post-hemodialysis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin and Blood Glucose Management in Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Requirements in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyperglycemia Management in Type 2 Diabetes with ESRD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What causes hypoglycemia (low blood sugar) during dialysis?
Will insulin requirements be higher the day after hemodialysis (HD)?
What is the appropriate acute and long‑term management of hypoglycemia in an adult patient receiving hemodialysis for end‑stage renal disease?
What causes intradialytic hypoglycemia?
How to manage hypoglycemia (low blood glucose) during hemodialysis?
What are the differential diagnoses and recommended work‑up for a 56‑year‑old man with a one‑month history of intermittent flushing and dizziness?
How can I improve medication adherence and diet in a non‑compliant patient with hypertension and type 2 diabetes mellitus who frequently forgets his antihypertensive drugs?
What are non‑hormonal alternatives to estrogen‑containing vaginal atrophy cream for a breast‑cancer patient with hormone‑receptor‑positive disease on tamoxifen or an aromatase inhibitor?
What is the weight‑based dosing guidance for subcutaneous testosterone pellets (Testopel® [testosterone]) and estradiol pellets in women, including recommended starting doses, dosing intervals, and monitoring parameters?
Does Truvada (emtricitabine/tenofovir disoproxil fumarate) affect renal function and what monitoring is recommended, particularly in patients with pre‑existing renal impairment, older age, hypertension, diabetes, or concomitant nephrotoxic medications?
What treatment options are appropriate for a 16‑year‑old male with bipolar disorder and aggression who cannot tolerate lamotrigine because of a severe adverse reaction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.